SALE ON NOW! PROMOTIONS

Close Notification

Your cart does not contain any items

$299.95

Hardback

Not in-store but you can order this
How long will it take?

QTY:

English
Elsevier - Health Sciences Division
16 June 2025
The Potential of Biomarkers: From Discovery to Clinical Application addresses the challenges related to knowledge dissemination, interdisciplinary understanding, diagnostic complexity, quality assurance, patient care, research advancement, education, and professional development within the field of clinical biochemistry. The book provides a holistic solution by offering comprehensive insights and practical guidance to a diverse audience, contributing to the enhancement of healthcare and biomedical research. Each chapter explores the multifaceted landscape of biomarker research, offering a wealth of insights and expertise in genomics, proteomics, metabolomics, and more.

Cancer biomarkers, the molecular signatures of cancer, hold immense promise in revolutionizing how we diagnose, treat, and personalize therapies for cancer patients. In this curated reference, esteemed contributors explore the multifaceted landscape of biomarker research, offering a wealth of insights and expertise in genomics, proteomics, metabolomics, and more.
Edited by:  
Imprint:   Elsevier - Health Sciences Division
Country of Publication:   United States
Dimensions:   Height: 235mm,  Width: 191mm, 
Weight:   450g
ISBN:   9780443292798
ISBN 10:   0443292795
Pages:   390
Publication Date:  
Audience:   Professional and scholarly ,  College/higher education ,  Undergraduate ,  Further / Higher Education
Format:   Hardback
Publisher's Status:   Active
1. Introduction: Navigating the Landscape of Cancer Biomarkers 2. Understanding the Role of Biomarkers in Cancer 3. Tools and Technologies for Biomarker Discovery 4. Genomic Biomarkers: Unraveling the DNA of Cancer 5. Proteomics and Protein Biomarkers in Oncology 6. Metabolomics: Metabolic Signatures in Cancer Biomarkers 7. Biomarker Validation and Regulatory Pathways 8. Clinical Trials and Studies for Biomarker Evaluation 9. Early Detection and Diagnostic Biomarkers 10. Prognostic Biomarkers: Predicting Disease Outcomes 11. Predictive Biomarkers: Guiding Personalized Cancer Therapies 12. Monitoring Treatment Response with Biomarkers 13. Ethical Considerations in Biomarker Research and Application 14. Challenges and Future Directions in Biomarker Development 15. Success Stories: Impactful Applications of Cancer Biomarkers 16. The Road Ahead: Advances and Innovations in Biomarker Science

Dr. Pranav Kumar Prabhakar is currently working as a Professor in the Department of Biotechnology at Nagaland University, Kohima, Nagaland, India. He has been listed among the World’s Top 2% Scientists (as published by Stanford University, USA, in 2021, 2022, 2023, and 2024). He earned his PhD in Biotechnology from IIT Madras. His primary research interests include elucidating molecular mechanisms and strategies for oral insulin delivery and mimicking signaling pathways in metabolic disorders (diabetes) using natural products. He is a member of the Royal Society of Chemistry and the Asia-Pacific Chemical, Biological & Environmental Engineering Society. He also serves as an editorial board member and reviewer for several reputed national and international journals. Dr. Pranav has received various honors, including a travel grant to attend ATTD 2009 in Greece, sponsored by the Indian Institute of Technology Madras and the Council for Scientific and Industrial Research (CSIR), and approved by the Department of Science and Technology (DST). He has published over 115 research articles in journals, authored or edited 17 books, contributed more than 40 book chapters, and delivered 9 oral and poster presentations at scientific meetings.

See Also